4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001799191-25-000006
Chief Financial Officer returned 1,150 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Carter Robert Ross Chief Financial Officer | 2025-03-19 | Returned to the company | −1,150 | $0.89 | $1,022 | 30,351 | D: show line 1 in the form |
Loading xslF345X05/wk-form4_1742507796.xml…